Treatment related adverse events in children with attention-deficit/hyperactivity disorder using atomoxetine

dc.authorid0000-0001-5207-6240en_US
dc.contributor.authorKasar, Nurdan
dc.contributor.authorYektaş, Çiğdem
dc.contributor.authorTufan, Ali Evren
dc.date.accessioned2023-06-14T12:32:30Z
dc.date.available2023-06-14T12:32:30Z
dc.date.issued2021en_US
dc.departmentBAİBÜ, Tıp Fakültesi, Dahili Tıp Bilimleri Bölümüen_US
dc.description.abstractObjective: The aim of our study is to evaluate treatment related adverse events in children with attention-deficit/hyperactivity disorder (ADHD) using atomoxetine. Material and Methods: One hundred eleven patients receiving atomoxetine treatment were included in this study. Evaluations were conducted with all participants and their parents using Turgay DSM-IV-Based Child and Adolescent Behavioral Disorders Screening and Rating Scale, Clinic Global Impression Scale and Atomoxetine Side Effect List. Results: Decreased appetite, irritability, loss of weight, fatigue, abdominal pain, constipation, change in sleep patterns, dizziness were common adverse effects of atomoxetine in our study. Diarrhea, rash and skin picking were rare. Changes in sleep patterns were more frequent in patients with the inattentive subtype (chi 2= 5.7, p=0.06, Cramer's V=0.25, Likelihood ratio). Patients using atomoxetine as the only treatment had constipation significantly more frequently than those receiving multiple regimens (p=0.02). Conclusion: Atomoxetine is generally safe and well tolerated. Further studies with a larger sample size are required to investigate adverse effects of atomoxetine treatment.en_US
dc.identifier.citationKasar, N., Yektas, C., & Ali, E. T. (2021). Treatment Related Adverse Events In Children With Attention-Deficit/Hyperactivity Disorder Using Atomoxetine. Psychiatry and Behavioral Sciences, 11(4), 243.en_US
dc.identifier.doi10.5455/PBS.20210419035444
dc.identifier.endpage248en_US
dc.identifier.issn2636-834X
dc.identifier.issue4en_US
dc.identifier.startpage243en_US
dc.identifier.urihttp://dx.doi.org/10.5455/PBS.20210419035444
dc.identifier.urihttps://hdl.handle.net/20.500.12491/11117
dc.identifier.volume11en_US
dc.identifier.wosWOS:000737456900003en_US
dc.identifier.wosqualityN/Aen_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.institutionauthorTufan, Ali Evren
dc.language.isoenen_US
dc.publisherYERKURE TANITIM & YAYINCILIK HIZMETLERI A Sen_US
dc.relation.ispartofPsychiatry and Behavioral Sciencesen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectADHDen_US
dc.subjectAtomoxetineen_US
dc.subjectAdverse Eventsen_US
dc.subjectDeficit Hyperactivity Disorderen_US
dc.subjectAdolescentsen_US
dc.titleTreatment related adverse events in children with attention-deficit/hyperactivity disorder using atomoxetineen_US
dc.typeArticleen_US

Dosyalar

Orijinal paket
Listeleniyor 1 - 1 / 1
Küçük Resim Yok
İsim:
nurdan-kasar.pdf
Boyut:
482.34 KB
Biçim:
Adobe Portable Document Format
Açıklama:
Tam Metin/Full Text
Lisans paketi
Listeleniyor 1 - 1 / 1
Küçük Resim Yok
İsim:
license.txt
Boyut:
1.44 KB
Biçim:
Item-specific license agreed upon to submission
Açıklama: